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Abstract
Background: The Millennium Development Goals (MDGs) availed opportunities for scaling up service coverage but 
called for stringent monitoring and evaluation (M&E) focusing mainly on MDG related programs. The Sustainable 
Development Goals 3 (SDGs) and the universal health coverage (UHC) agenda present a broader scope and require 
more sophisticated M&E systems. We assessed the readiness of low- and middle-income countries to monitor SDG 3.
Methods: Employing mixed methods, we reviewed health sector M&E plans of 6 countries in the World Health 
Organization (WHO) Africa Region to assess the challenges to M&E, the indicator selection pattern and the extent of 
multisectoral collaboration. Qualitative data were analysed using content thematic analysis while quantitative data were 
analysed using Excel.
Results: Challenges to monitoring SDG 3 include weak institutional capacity; fragmentation of M&E functions; 
inadequate domestic financing; inadequate data availability, dissemination and utilization of M&E products. The total 
number of indictors in the reviewed plans varied from 38 for Zimbabwe to 235 for Zanzibar. Sixty-nine percent of 
indicators for the Gambia and 89% for Zanzibar were not classified in any domain in the M&E results chain. Countries 
lay greater M&E emphasis on service delivery, health systems, maternal and child health as well as communicable diseases 
with a seeming neglect of the non-communicable diseases (NCDs). Inclusion of SDG 3 indicators only ranged from 48% 
for Zanzibar to 67% for Kenya. Although monitoring SDG 3 calls for multisectoral collaboration, consideration of the 
role of other sectors in the M&E plans was either absent or limited to the statistical departments. 
Conclusion: There are common challenges confronting M&E at county-level. Countries have omitted key indicators 
for monitoring components of the SDG 3 targets especially those on NCDs and injuries. The role of other sectors in 
monitoring SDG 3 targets is not adequately reflected. These could be bottlenecks to tracking progress towards SDG 
3 if not addressed. Beyond providing compendium of indicators to guide countries, we advocate for a more binding 
minimum set of indicators for all countries to which they may add depending on their context. Ministries of Health 
(MoHs) should prioritise M&E as an important pillar for health service planning and implementation and not as an 
add-on activity.
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Introduction
Health systems performance assessment (HSPA) through 
monitoring and evaluation (M&E) systems, has been a 
challenging enterprise which has attracted significant efforts 
in terms describing the processes, development of frameworks 
and tools, capacity building as well as recommendations of 
suitable indicators and information systems among others1-12 
– a testament of the importance of the subject matter. With 
ambitious global efforts towards universal health coverage 
and (UHC) and the Sustainable Development Goals (SDGs), 
the need for more comprehensive HSPA through effective 
M&E has become even greater.13 HSPA is a process that seeks 
to undertake a “health check” of the entire health system 
using statistical indicators, and links health outcomes to the 
strategies and functions of the health system.11 Monitoring 
is here defined as routine tracking and reporting of priority 
information about a program and its intended outputs and 
outcomes12 while evaluation measures how well the program 
has met expected objectives.14 The assessment of how well 
a health system has achieving desired results, which in 
this manuscript we refer to as HSPA, is assessed through 
M&E. Increasingly, it is recognised that comprehensive and 
transparent M&E is required not merely as a demonstration 
of accountability and evidence of the effectiveness of 
interventions, but also to make the case for additional health 
sector resources.12 Therefore, comprehensive M&E has 
become an integral element of every health sector strategic 
plan and much so for the UHC and SDGs agenda. 
Experiences from the Millennium Development Goals 
(MDGs) showed that regular monitoring was emphasised 
on MDG related programs and targets (maternal and child 
health, HIV, tuberculosis and malaria) and more attention 
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Implications for policy makers
• The Millennium Development Goals (MDGs) era availed opportunities for scaling up service coverage but also called for stringent monitoring 
and evaluation (M&E) requirements focussing mainly on MDG related programs (maternal and child health, HIV, tuberculosis and malaria). 
The Sustainable Development Goals 3 (SDG 3) ensure healthy lives and promote well-being for all at all ages; and the universal health coverage 
(UHC) agenda present a broader scope and call for more sophisticated M&E systems.
• Previous efforts in strengthening M&E have been characterised by vertical approaches, fragmentation and underfunding resulting in suboptimal 
performance of the M&E systems.
• The country adaptation of monitoring for SDG 3 and UHC as reflected in M&E plans shows varied considerations for the major parameters 
that must be reflected to adequately monitor UHC.
• The twenty-seven indicators for monitoring the 13 targets of SDG 3 should be given serious consideration by countries if not regarded as the 
minimum indicator set when developing M&E plans.
Implications for the public
Attaining Sustainable Development Goal 3 (SDG 3) targets and more important reaching universal health coverage (UHC) is every county’s aspiration 
but the starting point, as well as the path will be unique to each country. This underscores the need for strong monitoring and evaluation (M&E) to 
assess progress and in this regard, availability of M&E plans is crucial. Of concern however, are the institutional and systemic challenges to M&E; 
the burden of a high number of indicators selected; omission of some SDG 3 targets specifically for injuries, non-communicable diseases (NCDs) 
and associated risk factors and; the limited consideration for the much desired multisectoral collaboration in M&E for SDG 3 and UHC. Attaining 
UHC is a journey and M&E is key to ensuring progress. Our assessment provides important transferable lessons that can be contextualised to inform 
improvement in planning for M&E for SDG 3. 
Key Messages 
paid to global reporting without much integration with the 
overall health sector M&E needs of the country. This resulted 
in a multiplicity of monitoring indicators and vertical 
information systems to satisfy specific reporting obligations 
and in some cases meet the requirements of funders.15 The 
new direction of the global health agenda towards SDGs 
and UHC which embraces the broader socio-economic 
determinants of health and equity considerations presents 
broader and more sophisticated monitoring requirements. 
In this respect, the role of other sectors in the attainment of 
health-related targets and for that matter their incorporation 
in health sector performance assessments has become much 
more paramount. Embracing information sources from both 
within and without the health sector which is a characteristic 
of this multi-sectoral and inclusive approach advocated for by 
the SDGs is crucial. In this context, several critical components 
are relevant to HSPA including the activities involved – 
defined as all activities whose primary purpose is to promote, 
restore and/or maintain health irrespective of who undertakes 
these; and the people, institutions and resources involved in 
undertaking the activities, as well as how they are arranged 
and managed.10 This would concomitantly come with its own 
challenges or at least accentuate lingering M&E challenges 
within countries. 
Previous works drawing from international experiences 
have well-documented a myriad of challenges affecting 
comprehensive M&E leading to weak HSPAs.15-18 Some of these 
include the lack of good quality data, data incompleteness, 
poor timeliness to inform decision-making and exclusion 
of data from the private sector among others.17 On the 
other hand, high political interest and stewardship, clarity 
of vision for M&E with roles and responsibilities of actors 
spelt out, the involvement of stakeholders and strengthening 
of existing information systems as opposed to creating new 
ones are some of the promising lessons from countries.18,19 
Nevertheless, as part of efforts to track the health-related 
SDGs and UHC, countries are expected to develop M&E plans 
to track implementation of, and attainment of targets in their 
health sector plans. A review and synthesis of the challenges 
to be faced by countries in the SDG era would be useful for 
planning cross-country interventions for strengthening M&E. 
There has however been limited documentation or synthesis 
across countries to understand their own assessment of M&E 
challenges and priorities especially in the context of Africa. 
Towards a harmonised and comprehensive HSPAs, the 
International Health Partnership (IHP) (which evolved into 
UHC2030) developed a guide to be used by countries to develop 
their health sector M&E plans as a component of the health 
sector strategic plan, covering disease programs and health 
system actions.10 As such, a comprehensive HSPA is embedded 
primarily in a comprehensive M&E plan. Therefore, the IHP 
technical guidance urges countries to develop M&E plans that 
adopt a systematic results-chain representation comprising 
of four major domain/categorisation indicators namely, 
system inputs and processes, outputs, outcomes, and impact 
covering disease programs and health system strengthening 
interventions (eg, recruitment of health workers, putting 
information systems in place).10 Despite the international 
guidelines and other frameworks,7,9,15,16,18 the prioritisation of 
which indicators to select for the monitoring of health and 
health-related interventions is almost entirely the prerogative 
of countries. It is of interest however, to examine the pattern 
of country-level indicator selection especially in the light of 
the SDG 3 targets, an enterprise that has received limited 
intellectual effort. 
As part of efforts to expand the body of knowledge and 
strengthen efforts for HSPA through effective M&E, we 
analysed the health sector M&E plans of 6 African countries 
to synthesise their challenges, priority indicators selected 
for monitoring SDG 3 and UHC and consideration of other 
sectors in M&E. It is worth emphasising that the intent was not 
to perform a quality appraisal of the M&E plans using a ‘set of 
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standards’ but to provide a synthesis of common challenges 
confronting M&E in countries and explore their priorities 
based on the pattern of indicator selection amongst the 
countries. We acknowledge that some of the SDG 3 indicators 
may be monitored through other M&E frameworks, but we 
restrict our review to health sector M&E plans since our focus 
is on SDG 3 and, further note that the health sector goes 
beyond Ministry of health (MoH). 
Methods
A review of M&E plans of 6 countries within the World 
Health Organization (WHO) Africa Region (see Table 1) 
was conducted to synthesise the challenges and to identify 
indicator selection patterns. Here pattern refers to how many 
indicators were selected, selection of indicators for monitoring 
disease programs and health systems strengthening, and the 
selection of indicators for the different domains in the results 
chain. Consideration for the results chain derives from the 
need to show how inputs into the system (eg, financing, 
infrastructure) and processes (eg, supply chain) result into 
outputs (such as availability of services and interventions) 
and eventual outcomes (eg, intervention coverage) and 
impact (eg, improved health outcomes).12 The countries 
were conveniently selected if they had current and publicly 
available health sector strategic plan to which the M&E plans 
is aligned, M&E plan was also publicly available, the M&E 
plan covered the post-MDG period (after 2015), and country 
belonged to the WHO African Region. Based on these criteria, 
6 countries were selected for review and analysis. The review 
of each M&E plan was conducted independently by two 
persons guided by the format provided by the WHO/IHP+.12 
We kept the classification of indicators as initially classified 
the by countries in the different domains of the results chain. 
Indicators were further broadly grouped by countries into 
health systems, service delivery, communicable diseases, 
non-communicable diseases (NCDs) and those that measure 
overall population health status including maternal and child 
health among others.
Data Analysis
Two levels of analysis were conducted in line with the 
objective of the study. First, we manually conducted a content 
analysis of the situation analyses of the selected M&E plans 
to thematically synthesise the main challenges confronting 
M&E within the countries. The M&E plans were read by 
two people at different times in which each reviewer coded 
similar descriptions, phrases and words manually. The coded 
texts were then extracted into a separate sheet and checked 
for relevance to the objectives of the paper then mapped into 
themes. Each theme and subtheme were therefore supported 
with verbatim quote(s) taken from at least two of the M&E 
plans reviewed. Finally, the last author reviewed the M&E 
plans alongside with the identified themes as a confirmability 
check.
We reviewed the indicators in line with the WHO/IHP+ 
guidance12 which emphasises consideration for: 
1. Detailing a logical and results-chain – selection of 
indicators in the 4 major domain indicators namely, 
system inputs and processes, outputs, outcomes, and 
impact. We did not assess the reliability of the indicator 
selected; 
2. Indicators covering diseases programs and health systems 
strengthening; 
3. Inclusion of data sources and frequency of measurement; 
As well as the WHO guidance20 which emphasises:
4. Inclusion of SDG 3 related targets. As part of global 
efforts to monitor the 13 targets of SDG 3, there are 27 
indicators monitoring various aspects of the targets.
Secondly, a descriptive analysis of the indicators selected by 
countries was conducted to explore the pattern of selection. 
Subsequently, a parametric analysis using zero-order Pearson 
correlation was conducted using Statistical Package for Social 
Science (SPSS) to examine if the selection of a particular type 
of indicator was associated with the inclusion or exclusion of 
other types of indicators. Association between the different 
variables were considered statistically significant at 0.05 
criterion level.
Data Availability
All the reviewed M&E plans are in the public domain.
Patient and Public Involvement
Our study reviewed documents that were in the public 
domain. There was no involvement of patients or the public.
Results
The results of the review are presented in two main sections. 
The first section provides a synthesis of the challenges 
confronting M&E as identified in the situation analyses of 
reviewed plans. The second section is concerned with the 
analysis of the number and pattern of M&E indicators that 
were selected by countries including an assessment of the 
Table 1. Country M&E Plans Reviewed
Country Title of M&E Plan Timeframe
Guinea PNDS evaluation du 2015-2024
Kenya Health sector M&E framework 2014-2018
The Gambia The national M&E plan for the National Health Strategic Plan 2014-2020
Uganda M&E plan for implementation of the health sector development plan 2015/2016-2019/2020
Zanzibar M&E framework for health sector strategic plan III 2013/2014-2018/2019
Zimbabwe Zimbabwe health sector performance M&E policy guidelines and strategy 2016-2020
Abbreviations: M&E, monitoring and evaluation; PNDS, Plan national de suivi.
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number of indicators from each country that are aligned with 
the SDG 3 monitoring indicators.
Thematic Synthesis of Monitoring and Evaluation Challenges 
Within Countries
Content analysis of the situation analysis components of the 
M&E plans revealed common themes of challenges across 
the countries. These include weak institutional capacity and 
organisational structures for M&E in countries; inadequate 
coordination of partners; insufficient funding for M&E; 
inadequate dissemination and use of M&E products for 
decision-making. 
Weak Institutional Capacity and Organisational Structures for 
Monitoring and Evaluation
The situation analyses of the M&E plans revealed pervasive 
weaknesses in the institutional capacities of Ministries of 
Health (MoHs) for M&E owing to inadequate skilled personnel 
in M&E and suboptimal attention being paid to M&E 
functions when defining the structure and organograms at the 
MoHs. These gaps tend to be exacerbated at the subnational 
levels where in some cases, there are no designated officers 
to undertake M&E functions. For example, in Gambia’s M&E 
plan, it was bemoaned that “… there are inadequate resources 
(human, material and financial) to support M&E [resulting 
in] no reporting from the teaching hospital and the general 
hospitals unless the central team goes to actively collect 
data, which is often late…”21 Whereas in Uganda significant 
“progress [was made] towards aligning the previously 
fragmented information systems within the health sector to 
ensure contribution to the one M&E system” which resulted 
in improved data completeness and quality,22 however “… 
the M&E Structure for the MoH is not defined to streamline 
the M&E functions [particularly the] … absence of a human 
resource compliment for M&E at the MoH … [which] there 
is still [the] need for skills development for M&E” (p. 14). 
Similarly, in the case of Zimbabwe, “the human resource 
structures at provinces, districts and hospitals, respectively, 
are not formally structured to include the Provincial Health 
information officers, M&E officers, the District Health 
information officers and the Hospital Health information 
officers.”23 The foregoing situation was also aptly highlighted 
in Zanzibar’s M&E plan which noted that “human resources 
for [M&E] implementation remains inadequate at all levels of 
the health structure” (p. 15). Also, the penchant of creating 
parallel project management units or project implementation 
units within MoHs have also been implicated in weakening 
the capacity of the MoH’s planning, M&E units.21,22
Fragmentation of Monitoring and Evaluation Function With 
Inadequate Coordination Mechanisms
Another challenge that cut across the M&E situation analyses 
of 6 different countries related to the weak coordination of the 
M&E processes especially within the MoH where roles and 
functional relationships between the various departments 
such as information technology, health information/statistics, 
disease programs and planning departments were not clearly 
defined in terms of their role in M&E. Even so, external 
coordination and stewardship with development partners 
and counterpart Government’s Ministries, Departments and 
Agencies (MDAs) leaves much to be desired. In the Gambia 
for instance, it was pointed out that “the roles, responsibilities 
are not very clear …with minimal coordination between the 
different technical units, the directorates, the broader health 
sector stakeholders and the sub-national levels, especially 
the regions”21 similar to Guinea24 where “there are several 
fragmented health information subsystems … that are 
managed by different ministries and national institutions 
with an obvious weakness of coordination” (p. 22). The 
situation analysis of the Kenyan M&E plan also described 
the prevailing M&E ecosystem prior to the development of 
the plan as “… disjointed, with no coordination structures or 
framework … [where the] numerous programme specific/
disease-based M&E systems operate separately, not sharing 
data and information with each other.”25 This “prevailing 
absence of a unified approach to monitoring programmatic 
and sector performance has created duplication of effort, 
inefficiencies, lagging capacity in the analysis of health 
system performance and in implementing comprehensive 
M&E” (p. 14). Similarly, it was identified in Zimbabwe that 
“fragmented/vertical programme specific M&E units are 
working in silos” (p. 38). These weak linkages are said to have 
led to “inadequate sharing of information” for health system 
performance assessment in Zanzibar26 and “poor timing 
in the provision of results for guiding sector planning” in 
Uganda.22 Additionally, low reporting rates from the private 
sector have been attributed to the weak coordination which in 
turn limited the ability to appropriately monitor overall sector 
performance in some of the countries.21,23,25
Inadequate Domestic Monitoring and Evaluation Financing 
Resulting in Donor Dependence
Inadequate domestic financing for M&E has created major 
gaps that impede effective implementation and monitoring 
of the National Health Strategic Plans.21 Undoubtedly, most 
African countries are faced with insufficient domestic 
resources to meet all the needed investments in the health 
sector27 resulting in gaps in critical areas including M&E 
such that even “quarterly reports and reviews between the 
[MoH and sub-national levels] are mostly donor-funded.”23 In 
Zanzibar, it was re-echoed that “insufficient funds … was the 
major constraint to [M&E] implementation,” noting that “… 
the markedly limited government budget for HMIS [Health 
Management Information System] led to over-reliance on 
donor project resources often associated with piece-meal 
initiatives” (p. 14). Even in the case of Uganda where M&E 
appears to be one of the strong points of the health system, it 
was noted there are still “irregular program and sub-national 
performance reviews due to inadequate funds” (p. 15) resulting 
in “evaluations for most programs not conducted … and as a 
result impact of interventions [also] not well-documented” 
(p. 15). 
Inadequate Data Availability
The unavailability of data was identified as one of the major 
setbacks of effective M&E across the plans of the countries 
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under review. This has partly been linked to M&E processes 
intricately anchored on the functionality and quality of 
HMIS with the aim of ensuring timeliness, completeness 
and accessibility to all stakeholders. However, the review 
shows that monthly reporting is not always complete and 
timely21,25 which is sometimes attributed to the inadequate 
supply of relevant tools for data collection and reporting. 
Other challenges relate to the misclassification and ultimately 
inaccurate estimates of disease burden due to limited use of the 
International Classification of Diseases (ICD). For example 
in Uganda, only 13 out of 335 health facilities were using the 
ICD 10. Similarly, in the Gambia, it was identified that “the 
ICD is not used despite previous recommendations” which 
coupled with the absence of community-based information 
system is undermining data quality and hence effective M&E.
Inadequate Dissemination and Utilization of Monitoring and 
Evaluation Products
Another common theme that run across the M&E plans is 
the phenomenon of minimal use of evidence from routine 
M&E processes for decision-making. The Zanzibar’s M&E 
plan, for instance, noted that “… analysis, synthesis, effective 
dissemination and use of information to guide policy 
dialogue and implementation of health programmes remain 
a challenge,”26 an assertion that is corroborated by Uganda’s 
M&E plan which reiterated that “the utilization of data for 
decision-making is still minimal” (p. 15). The challenge has 
not only been partly attributed to untimely reporting as noted 
in the Zimbabwe M&E plan but also an endearing “weak 
culture of data demand and use of information for decision-
making.”25 
Descriptive Analysis of Indicators Selected by Countries
The countries reviewed largely followed a systematic results 
chain framework as proposed by IHP guidance12,20 in 
developing their respective M&E plans by selecting indicators 
to monitor the use of inputs, processes, outputs, outcomes 
and demonstrable impact at the population level. In total, 
614 indicators were selected by the 6 countries which varied 
widely from 38 indicators in the case of Zimbabwe to as 
many as 235 for Zanzibar. As shown in Table 2, across the 6 
countries, 55.5% (n = 341) of the selected indicators were not 
classified by the countries as to whether they were intended 
to measure inputs/processes, outputs, outcomes or impact, 
in that, as high as 210 indicators (89%) for Zanzibar and 93 
(69%) for The Gambia were not classified. Overall, about 
10% (n = 62) of the selected indicators were classified by 
the respective countries as measuring inputs and processes 
while 9% (n = 60) were intended to measure outputs; 16% 
(n = 97) to measure outcomes and 9% (n = 54) to measure 
impact in terms of population health status. For three of the 
countries (Uganda, Kenya, and Guinea) that classified all 
their selected indicators, an average of 22% of the indicators 
were intended to measure inputs/processes, 21% intended to 
measure outputs, 39% to measure intermediate outcomes and 
18% intended to measure the impact of various interventions 
on population health status. 
Also, the indicators in the reviewed M&E plans were broadly 
grouped into health systems, service delivery, communicable 
diseases, NCDs and those that measure overall population 
health status including maternal and child health among 
others. As shown in Table 2, except for Zimbabwe (15.8%) 
and Zanzibar (4.3%), about 49.4% of the selected indicators 
of the other four countries were focused on service delivery 
which ranged from 42% for Kenya to 61.9% for Uganda. 
Furthermore, between 17% (Uganda) and 48% (The Gambia) 
of the indicators also focused on health system issues. Only 
Uganda prioritised nearly 10% of the selected indicators to 
monitor risk factors for NCDs as the other five countries 
selected between 4% and 6% of the indicators intended 
for monitoring NCDs risk factors. Similarly, health status 
indicators which measure more of the impact of interventions 
on the population health represented 6% of the total number 
of indicators, ranging from 4% in three countries (Zimbabwe, 
Zanzibar, and the Gambia) to 12% in Kenya. 
Across the countries, most indicators had baseline values, 
targets and frequency of reporting but there were also some 
omissions. For example, The Gambia had some indicators 
whose baseline were not available, but future targets were 
set. In the case of Zimbabwe, the source(s) of data for 
each indicator was not stated explicitly but rather generic 
data sources were listed including their frequency of data 
generation/compilation. 
In giving effect to the concept of leaving no one behind 
embedded in the UHC agenda, several equity dimensions in 
terms of monitoring access to needed services by population 
sub-classes such as socio-economic status, residence, gender, 
religion and race were looked out for in the M&E plans 
reviewed. As shown in Table 2, all the M&E plans made 
provision for including some equity stratification except for 
The Gambia’s M&E plan which made no consideration for 
equity analysis, while Zimbabwe considered only geographical 
and gender stratification. Surprisingly, however, none of the 
M&E plans paid attention to monitoring access to services by 
the elderly.
Correlation Between Selection of Indicator Types
A linear correlation was conducted to explore the relationships 
between the pattern of selection of input/process, output, 
outcome and impact indicators by countries. As shown in 
Table 3, the results revealed that the countries that had a 
high number of unclassified indicators in the M&E plan were 
associated with a significantly decreased number of input/
process indicators (r = -0.97); output indicators (r = -0.38) 
and impact indicators (r = -0.61) but associated with a higher 
number of outcome indicators (r = 0.98). In contrast, a positive 
correlation was observed between the selection of inputs/
processes indicators on one hand and on the other hand, 
output indicators (r = 0.12), outcome indicators (r = 0.40) as 
well as impact indicators (r = 0.31). It is also worth noting that 
a negative but statistically insignificant relationship (r = -0.04) 
was observed between the selection of output indicators and 
that of outcome indicators. 
It can be inferred from this finding that if the countries 
were to classify all the remaining unclassified indicators, most 
of these could have been input/process and impact indicators 
Nabukalu et al
International Journal of Health Policy and Management, 2020, 9(7), 297–308302
Table 2. Analysis of the Selection of Core Indicators in Country M&E Plans
Country Indicator Domain
Classification and Number (%) of Indicators Mechanism for Tracking
Unclassified
Input/
Process Output Outcome Impact
Total 
Domain
Data Sources 
Indicated
The Frequency 
of Reporting 
Indicated
Baseline 
Provided
Equity Stratifies 
Identified
Targets Set
Uganda
Health systems 7 (100) 7 (17) Y Y Y Y Y
Service delivery 13 (50) 13 (50) 26 (62) Y Y Y Y Y
NCDs risk factors 4 (100) 4 (10) Y Y Y Y Y
Health status 5 (100) 5 (12) Y Y Y Y Y
Total 7 (17) 13 (31) 17 (40) 5 (12) 42 (100)
Kenya
Health systems 32 (80) 8 (20) 40 (40) Y Y Y Y Y
Service delivery 5 (12) 10 (24) 27 (64) 42 (42) Y Y Y Y Y
NCDs risk factors 6 (100) 6 (6) Y Y Y Y Y
Health status 12 (100) 12 (12) Y Y Y Y Y
Total 37 (37) 10 (10) 41 (41) 12 (12) 100 (100)
The Gambia
Health systems 54 (83) 6 (9) 5 (8) 65 (48) Y Y N N N
Service delivery 39 (64) 13 (21) 1 (2) 8 (13) 61 (45) Y Y For 70 of indicators N For 50 of indicators
NCDs risk factors 5 (100) 5 (4) Y Y N N N
Health status 4 (100) 4 (3) Y Y Y N Y
Total 93 (69) 6 (4) 18 (13) 6 (4) 12 (9) 135 (100)
Zanzibar
Health systems 4 (57) 2 (29) 1 (14) 7 (3) Y Y Y Y N
Service delivery 3 (30) 7 (70) 10 (4) Y Y Y Y Y
NCDs risk factors 4 (100) 4 (2) Y Y Y Y Y
Health status 4 (100) 4 (2) Y Y Y Y Y
Not classified into domains 210 (100) 210 (89) N N N Y N
Total 210 (56) 10 (3) 23 (6) 17(5) 21 (6) 374 (100)
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Zimbabwe
Health systems 12 (100) 12 (32) Yes, but not by 
indicators
Yes, but not by 
indicators
Y Geographical and gender Y
Service delivery 6 (100) 6 (16) Not explicitly Not explicitly Y Geographical and gender Y
Communicable diseases 8 (100) 8 (21) Not explicitly Not explicitly Y Geographical and gender Y
NCDs 4 (100) 4 (11) Not explicitly Not explicitly N Geographical and gender Y
Maternal and child health 4 (100) 4 (11) Not explicitly Not explicitly Y Geographical and gender Y
Emergencies 4 (100) 4 (11) Not explicitly Not explicitly Y Geographical and gender Y
Total 38 (100) 38 (100)
Guinea
Health systems 8 (67) 1 (8) 3 (25) 12 (19) Y Y 70% of indicators Y 70% of indicators
Service delivery 13 (42) 18 (58) 31 (48) Y Y Y
Communicable diseases 9 (100) 9 (14) Y Y Y
NCDs 4 (80) 1 (20) 5 (8) Y Y Y
Health status 7 (100) 7 (11) Y Y Y Y
Total Total 8 (13) 14 (22) 22 (34) 20 (31) 64 (100)
Overall 341 (56) 62 (10) 60 (10) 97 (16) 54 (9) 614 (100)
Abbreviations: M&E, monitoring and evaluation; NCDs, non-communicable diseases.
Country Indicator Domain
Classification and Number (%) of Indicators Mechanism for Tracking
Unclassified
Input/
Process Output Outcome Impact
Total 
Domain
Data Sources 
Indicated
The Frequency 
of Reporting 
Indicated
Baseline 
Provided
Equity Stratifies 
Identified
Targets Set
Table 2. Continued
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and a relatively small number being output indicator. 
Alignment of the Country Selected Indicators With Sustainable 
Development Goal 3 Monitoring Indicators
For country M&E plans under review, we examined the extent 
of alignment of the country selected indicators with those of 
the SDG 3 targets. Alignment here means that the country 
selected that particular indicator but with a country specific 
target. On average, the M&E plans included 58% of the SDG 
3 indicators. Kenya’s M&E plan contained the most (66.7%, n 
= 18) indicators aligned with SDG 3 followed by Zimbabwe 
(63%, n = 17) with the least number of SDG 3 indicators 
being included in the Zanzibar M&E plan (48.1%, n = 13). 
It is important to point out that none of the M&E plans 
included any of the SDG 3 indicators that monitors target 
3.9 to by 2030, substantially reduce the number of deaths and 
illnesses from hazardous chemicals and air, water and soil 
pollution and contamination. Similarly, none of the M&E 
plans included the only indicator that monitors target 3.a 
which seeks to strengthen the implementation of the WHO 
Framework Convention on Tobacco Control in all countries. 
Only Kenya’s M&E plan included indicators aligned with the 
monitoring of SDG 3 targets 3.5 and 3.6 which, respectively, 
seek to strengthen the prevention and treatment of substance 
abuse, including narcotic drug abuse and harmful use of 
alcohol; and by 2020, halve the number of global deaths and 
injuries from road traffic accidents. The foregoing reinforces 
the finding that countries somehow did not adequately 
prioritise indicators that support the monitoring of risk 
factors for NCDs. Nevertheless, the countries included all the 
indicators meant for tracking targets 3.1 and 3.2 which are 
both maternal and child health-related targets. See Table 4 for 
details on the extent of alignment between the country M&E 
plans and the SDG 3 indicators. 
Consideration of Other Sector’s Roles
The health sector is broader than the MoH and indeed the 
broad SDG 3 agenda and attainment of UHC calls for multi 
sector collaboration. This implies, health-related activities 
that are core to the attainment of UHC will be implemented 
by other sectors and likewise some of the health-related 
indicators (eg, Death rate due to road traffic injuries) will be 
housed in other sectors. As shown in Table 5, consideration 
for multi sectoral collaboration in M&E is limited. Only the 
statistics unit/department is reflected in 3 of the countries. 
Consideration for cabinet in The Gambia and Zanzibar is 
commended given their role in resource allocation.
Discussion 
Tracking the progress being made in countries towards 
UHC and the SDG 3 necessitates that the planning and 
implementation of intervention are inextricably linked to 
M&E.7 Against this backdrop, we reviewed the situation 
analyses of M&E plans for 6 African countries which showed 
common themes of challenges confronting M&E, some 
of which were being addressed by the M&E plans whilst 
others were beyond the scope of the plans. Particularly 
weak institutional capacity and organisational structures 
for M&E; fragmentation of M&E functions with inadequate 
coordination mechanisms; inadequate domestic financing for 
M&E resulting in donor dependence; limited attention paid 
to multisectoral approaches, inadequate data availability as 
well as dissemination and utilization of M&E products for 
decision-making were common in the situation analyses of 
the M&E plans of the countries. 
These findings corroborate previous analysis and 
commentaries that also cited inadequate attention paid to the 
multisectoral collaboration required in data generation and 
use; weak capacity; coordination inadequacies; the donor-
driven and narrow focus health information system as the 
main drawbacks of M&E in developing countries especially 
in Africa.4,18 Whilst the findings may not be entirely new, 
their continued existence if not exacerbation despite various 
efforts in the past signifies their chronicity and potential to 
undermining the tracking of global and local efforts towards 
the attainment of UHC and SDG 3. These challenges if not 
addressed could lead to frustration and resentment towards 
M&E which would eventually drawback the ability of 
countries and partners to track the progress (or otherwise) 
towards the global health agenda. The Kenyan M&E plan 
characterises this potential situation as health workers at the 
facility and community level were frustrated by burdensome 
demands for data while health managers and planners 
were also frustrated by the competing demands and lack of 
capacity to adequately respond to those demands; national-
level planners becoming frustrated by lack of information 
relevant to policy and decision-making and; funders (both 
internal and external) also frustrated because they cannot 
effectively assess the impact of their support.25 The non-use 
of evidence for decision-making was also cited which perhaps 
is the conduit for not prioritizing M&E in terms of resource 
allocation from domestic sources. 
Furthermore, the analysis found that the M&E plans of 
the 6 countries had a total of 614 indicators which varied 
widely from one country to another, ranging from 38 to 235 
indicators. More than half of the total indicators (55.5%) were 
Table 3. Correlation Between Types of Indicators Selected by Countries
Variables Input/Process Indicators Output Indicators Outcome Indicators Impact Indicators
Unclassified indicators -0.97* -0.38* 0.98* -0.61*
Input/process indicators 0.12* 0.40* 0.31*
Output indicators -0.04NS 0.70*
Outcome indicators    0.46*
*P < .05; NS, not statistically significant.
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Table 4. Analysis of SDG 3 Target Indicators Selected by Countries
SDG 3 Targets
Number of 
Indicators for 
SDG Targets
Number Selected by Countries
Uganda Kenya The Gambia Zanzibar Zimbabwe Guinea 
3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100 000 live births 2 2 2 2 2 2 2
3.2 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at 
least as low as 12 per 1000 live births and under-5 mortality to at least as low as 25 per 1000 live births
2 2 2 2 2 2 2
3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and 
other communicable diseases
5 3 4 4 2 4 4
3.4  By 2030, reduce by one-third premature mortality from NCDs through prevention and treatment and promote mental health and well-being 2 0 1 0 0 1 1
3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol 1 0 1 0 0 0 0
3.6 By 2020, halve the number of global deaths and injuries from road traffic accidents 2 0 1 0 0 0 0
3.7 By 2030, ensure universal access to sexual and reproductive healthcare services, including for family planning, information and education, and 
the integration of reproductive health into national strategies and programmes
2 2 1 2 1 2 1
3.8 Achieve UHC, including financial risk protection, access to quality essential healthcare services and access to safe, effective, quality and 
affordable essential medicines and vaccines for all
2 2 2 2 2 2 1
3.9 By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and 
contamination
3 0 0 0 0 0 0
3.a Strengthen the implementation of the WHO Framework Convention on Tobacco Control in all countries, as appropriate 1 0 0 0 0 0 0
3.b Support the research and development of vaccines and medicines for the communicable and NCDs that primarily affect developing countries, 
provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public 
Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual 
Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
3 2 2 2 2 2 2
3.c Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing 
countries, especially in the least developed countries and small island developing States
1 1 1 1 1 1 1
3.d Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and 
global health risks
1 1 1 1 1 1 1
Total 27 15 18 16 13 17 15
Percentage of indicators selected by countries 55.6% 66.7% 59.3% 48.1% 63.0% 55.6%
Abbreviations: NCDs, non-communicable diseases; UHC, universal health coverage; SDG, Sustainable Development Goal; WHO, World  Health Organization; TRIPS, Trade-Related Aspects of Intellectual Property Rights.
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Table 5. Role of Other Sectors in M&E as Reflected in the Plans
Country Line ministries Roles
Uganda
Ministry of foreign affairs (National 
identification registration authority) 
Operating and managing the Civil Events Registry.
Timely processing and dissemination of Vital Statistics.
Capacity building of health providers and community in registration of births and deaths.
Provision of registration equipment and materials.
Ministry of Finance – UBoS
Coordinating, supporting, validating and designating as official any statistics produced by UBoS, 
MDAs, and LGs.
Coordinating and clearing all censuses and nationally representative household economic surveys.
Ensuring production, harmonization and dissemination of statistical information.
Strengthening statistical capacity of planning units in MoH and local governments for data production 
and use.
Ensuring best practice and adherence to standards, classifications, and procedures for statistical 
collection, analysis and dissemination in MoH and LGs.
Ensuring that complete and approved health statistical data are made easily available to the public in 
a timely manner, while ensuring that the sharing of reports respects the Access to Information Act, 
2005.
Kenya Ministry of Devolution & Planning Ensure functional linkage with MoH.
The Gambia
Cabinet/Parliament 
 
Overall political and policy oversight. 
Review of sector progress in the past year (based on the AHSPR), against the policy imperatives set out 
in contribution towards the second NHP and NDP. 
The health sector shall interface with parliament and cabinet whenever necessary and during the JRM 
of the health sector.  
Bureau of Statistics (GBoS)
Coordinating, supporting, validating, and designating as official any statistics produced by GBoS.
Coordinating and clearing all censuses and nationally representative household economic surveys. 
Ensuring production, harmonization and dissemination of statistical information. 
Strengthening statistical capacity of planning units in MoH and LGs for data production and use. 
Ensuring best practice and adherence to standards, classifications, and procedures for statistical 
collection, analysis and dissemination in MoH and LGs. 
Ensuring that complete and approved M&E reports and health statistical data are made easily available 
to the public in a timely manner. 
Zanzibar
House of Representative/Cabinet/
Parliament
Overall political, and policy oversight. 
Review of sector progress in the past year (based on the AHSPR), against the policy imperatives set out 
in contribution towards MoH achievements. 
The OAG
Carrying out audits and providing reports on public accounts of all public offices and any public 
corporation or other bodies established by an Act of Parliament. 
Conducting financial, value for money and other audits, such as gender and environment audits, in 
respect of any project or activity involving public funds. 
Office of Government Statistician 
Zanzibar 
Coordinating, supporting, validating and designating as official any statistics produced by OCGS MDAs 
and LGAs. 
Coordinating and clearing all censuses and nationally representative household economic surveys. 
Ensuring production, harmonization and dissemination of statistical information. 
Strengthening statistical capacity of planning units in MoH and LGAs for data production and use.
Ensuring best practice and adherence to standards, classifications, and procedures for statistical 
collection, analysis and dissemination in MoH and LGAs. 
Ensuring that complete and approved M&E reports and health statistical data are made easily 
available to the public in a timely manner, while ensuring that the sharing of reports respects the 
access to information deliberations. 
Zimbabwe None stated  
Guinea None stated  
Abbreviations: MoH, Ministry of Health; M&E, monitoring and evaluation; OAG, Office of the Auditor General; UBoS, Uganda Bureau of Statistics; MDAs, 
Ministries, Departments and Agencies; GBoS, Gambia Bureau of Statistics; LGs, local governments; AHSPR, annual health sector performance report; NHP, 
national health policy;  NDP, national development plan; JRM, joint review mission; OCGS, Office of the Commissioner General Statistics. 
not classified on a results chain framework. The negative but 
statistically insignificant relationship between the selection 
of output indicators and that of outcome indicators observed 
in this analysis may be underpinned by a seemingly narrow 
distinction between the outputs and outcome indicators 
selected by countries. The high number of indicators was 
found to be attributed to various interests such as funders and 
programmatic plans, fueled by standalone health information 
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systems.1,28,29 Even though there has not been a benchmark 
of an ‘optimal’ number of indicators for countries in either 
literature or operational guidelines, having to monitor too 
many indicators has been shown to be burdensome and could 
in itself become a drawback to the sustainability of effective 
M&E especially in the context of countries with suboptimal 
technological, financial and human resource capacity.4,30,31 
Therefore, we recommend that as part of the health sector 
strategic planning process, countries should intensify the 
M&E planning dialogue to minimise possible redundant 
indicators, some of which may never get analysed and 
reported throughout the lifespan of the M&E plan. There is 
evidence to this effect and an example is the case of Eswatini 
where at the end term evaluation of the strategic plan, there 
was no data to report on 60% of the indicators.32
Although SDG 3 which is broader in scope than the MDGs 
embraces efforts to tackle the rising challenge of NCD, the 
analysis in this review suggests that countries continued to 
lay greater M&E emphasis on service delivery issues, health 
systems, maternal and child health as well as communicable 
diseases as was seen in the MDG era. There is a seeming neglect 
of the NCDs and their risk factors which are fast becoming the 
leading cause of morbidity and mortality in many countries 
and accounted for 71% of global deaths in 2016.32 If the trend 
of not adequately prioritizing NCDs indicators in M&E plans 
is widespread beyond the sampled country M&E plans under 
review, it could have dire consequences for tracking the 
progress made in the fight against NCDs including injuries 
which will ultimately undermine the first of triple billion 
targets of WHO which is “1 billion more people benefiting 
from UHC” and SDG 3 in general. Therefore, beyond 
providing M&E frameworks and compendium of indicators 
to guide countries, we advocate for a more binding minimum 
set of indicators which could be added upon by countries 
depending on their context and needs. 
Added to the aforesaid, the analysis revealed that despite the 
numerous indicators selected in the country M&E plans, they 
averagely included only 58% (range: 48%-67%) of the SDG 
3 indicators. Indeed, countries that had the most indicators 
tended to include fewer SDG 3 monitoring indicators. This 
implies that in the countries under consideration, the routine 
monitoring mechanism may not provide sufficient and 
relevant information for comprehensive monitoring of the 
SDG 3 targets. Thus, they may end up needing additional 
effort to be able to fulfil the SDG 3 monitoring requirement 
which may, in turn, reinforce the challenges of non-integration 
and multiplicity of reporting requirements against a backdrop 
of limited funding. Furthermore, there was suboptimal 
consideration for equity analysis in the reviewed plans. The 
resource implications of extensive equity analysis on a routine 
basis could justify some countries adopting an incremental 
approach by starting with a minimal stratification with the 
hope of adding more as the M&E systems become more 
robust.
There are global efforts to support strengthening M&E at 
country level and among these is the Health data collaborative 
which seeks to align partner resources and interventions to 
the country M&E, engage a wider set of actors including the 
private sector and tracking progress in country capacity to 
monitor the health-related SDGs. There are positive lessons 
from Kenya with regards to partner alignment to one M&E 
plan.19 
Strengths and Limitations of the Study
The health sector’s vision in strengthening M&E is laid down 
in M&E plans which guides investments and interventions 
of all actors. Our assessment of M&E plans gives inference 
on the likely robustness of M&E systems to monitor SDG 
3 targets. We however note that a good plan may not 
necessarily translate into strong M&E systems because the 
implementation step is not always guaranteed. We reviewed 
few M&E plans,6 the findings from these as well as the 
recommendations made, may not be representative of the 
African region. We acknowledge that some of the SDG 3 
indicators may be monitored through other M&E plans 
and as such missed in our review. In addition, we reviewed 
publicly available plans, additional challenges and insight may 
have been gained through interviews with key stakeholders 
in these countries. We however believe there are important 
lessons that can inform improvement in planning for M&E for 
SDG 3. Three of the plans (Kenya, The Gambia, and Zanzibar) 
were developed prior to the starting date of implementing 
SDGs, however, these were still guiding M&E activities and as 
such we justified to review them. 
Conclusion 
With more ambitious international health goals and targets 
together with increasing demand for social accountability in 
health, there is a growing interest in assessing the performance 
of health systems especially in developing countries where 
health system efficiencies continue to raise concerns.4,33 An 
analysis of M&E plans of 6 countries in the WHO Africa 
Region re-echoed common themes of challenges confronting 
effective M&E at county level such as weak institutional 
capacity; weak coordination; inadequate domestic funding 
for M&E and suboptimal data availability. Amidst the global 
affirmation of the SDG 3 and UHC by all countries, the 
analysis showed that inadvertently or otherwise, countries 
had omissions of indicators for monitoring key components 
of the SDG 3 targets especially those on NCDs and injuries 
in favour of targets that were the bedrock of the MDG era. 
We conclude that on the back of the numerous challenges 
confronting effective M&E at county level, and the high 
number of indicators in the M&E plans majority of which 
are not properly aligned to logical results chains and the SDG 
3 indicators, these could prove to be significant bottlenecks 
to tracking progress if they are not addressed. Therefore, 
increased efforts in strengthening M&E capacity in countries 
is strongly advocated for while MoHs should also prioritise 
M&E as an important pillar for health service planning and 
implementation; not an ad-hoc add-on activity. Additionally, 
a critical assessment of the relevance of an indicator needs 
to be undertaken to ensure that a manageable number of 
indicators are selected that can adequately assess health 
sector performance and progress towards UHC. We further 
contend that the 27 indicators monitoring the 13 targets of 
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SDG 3 should be given serious consideration by countries if 
not regarded as the minimum indicator set when developing 
M&E plans. 
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